What question did this study set out to answer?

To determine the role of endogenous lipid mediators, particularly platelet-activating factor and leukotrienes derived via 14 kDa phospholipase A2, in driving inflammatory angiogenesis.

May 1, 1998Biochimica et Biophysica Acta (BBA) - Lipids and Lipid MetabolismOpen Access

The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis

View Full Paper

Ask AI

Bookmark

To determine the role of endogenous lipid mediators, particularly platelet-activating factor and leukotrienes derived via 14 kDa phospholipase A2, in driving inflammatory angiogenesis.
Evaluated inflammatory angiogenesis using a murine air pouch granuloma model at day 6.
Administered pharmacological inhibitors targeting 14 kDa phospholipase A2 (SB 203347), 5-lipoxygenase (zileuton), and the platelet-activating factor receptor (Ro 24-4736).
Measured tissue concentrations of leukotriene B4, platelet-activating factor, and prostaglandin D2 alongside changes in vessel growth.
Inhibition of 14 kDa phospholipase A2 by SB 203347 decreased leukotriene B4 and platelet-activating factor levels without altering prostaglandin D2, which correlated with a significant reduction in angiogenesis.
Inhibition of 5-lipoxygenase by zileuton reduced leukotriene B4 levels but did not significantly suppress angiogenesis.
Selective blockade of the platelet-activating factor receptor using Ro 24-4736 potently reduced angiogenesis.

Structured PICO

Population

Murine air pouch granuloma model of inflammatory angiogenesis

Intervention

SB 203347 (14 kDa PLA2 inhibitor), zileuton (5-lipoxygenase inhibitor), or Ro 24-4736 (PAF receptor antagonist)

Outcome

Angiogenesis and levels of LTB4, PAF, and PGD2 in the day 6 granulomasurrogate

Platelet-activating factor (PAF) contributes significantly to the angiogenic phenotype in chronic inflammation in a murine model.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

PAF antagonists reduce angiogenesis in murine inflammation; hypothesis-generating for PAF-targeted therapies in human chronic disease.

Cite This Study

Jackson et al. (1998) studied this question.

synapsesocial.com/papers/6a855a0d6615ae7d6e4e1a39 https://doi.org/10.1016/s0005-2760(98)00012-5

View Full Paper

Ask AI

Bookmark

The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis

Key Points

Structured PICO

Discussion

Implication

Cite This Study

The role of platelet activating factor and other lipid mediators in inflammatory angiogenesis

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider